Exploiting GSK3β′s multifaceted role in these areas is increasingly seen as a promising strategy for enhancing the efficacy of cancer treatments, potentially leading to improved patient outcomes (JA et al., 2014). The gene discussed is GSK3B; the disease is cancer.